CanDI

CanDI integrates heterogeneous cancer-related datasets by retrieving and indexing public and user-provided data to enable synthesis of multi-source genomic and functional information for hypothesis generation and therapeutic target identification.


Key Features:

  • Retrieval and indexing framework: Systematic retrieval and indexing of publicly available datasets to support consolidated querying and analysis.
  • User dataset integration: Incorporation of user-specific or bespoke datasets alongside public resources for customized analyses.
  • Continuous data updates: Ongoing incorporation of new data to maintain the currency of integrated datasets.
  • Hypothesis generation: Integrated analysis facilitates identification of synthetic lethal gene pairs, genes associated with sex disparity in cancer, and potential immunotherapy targets.

Scientific Applications:

  • Large-scale cancer data integration: Consolidation of multi-source genomic and functional datasets for comprehensive analysis of cancer biology.
  • Discovery of genetic interactions: Identification of synthetic lethal relationships and genes linked to sex disparities in cancer.
  • Immunotherapy target identification: Support for discovery of candidate immunotherapy targets through integrated multi-dataset analysis.
  • Therapeutic target prioritization: Facilitation of prioritizing candidate targets and generating testable hypotheses for experimental validation.

Methodology:

Systematic retrieval and indexing of data from public sources and integration of user-specific datasets to enable cohesive analysis of data from disparate origins.

Topics

Details

License:
MIT
Cost:
Free of charge
Tool Type:
library
Operating Systems:
Mac, Linux, Windows
Programming Languages:
Python
Added:
4/2/2022
Last Updated:
4/2/2022

Operations

Data Inputs & Outputs

Data retrieval

Publications

Yogodzinski C, Arab A, Pritchard JR, Goodarzi H, Gilbert LA. A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy. Genome Medicine. 2021;13(1). doi:10.1186/s13073-021-00987-8. PMID:34663427. PMCID:PMC8524992.

PMID: 34663427
PMCID: PMC8524992
Funding: - National Institutes of Health: DP2 CA239597, K99/R00 CA204602